With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Discover how the synergy between AI and cell-free systems is driving a new era in biopharma innovation, accelerating drug ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

With the advent of machine learning and artificial intelligence, materials science could be poised to take its next big leap ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

A new study in Nature by last year's Nobel Laureate in Chemistry reveals a possible game-changer in snakebite treatment.

Healthcare technology company Innovaccer announced its acquisition of Humbi AI, an actuarial software, services and analytics ...